Trials / Completed
CompletedNCT01978678
Does Asthma Phenotype Have Impact on Disease Control
Does Asthma Phenotype Have Impact on Disease Control - Can Detection of Inflammation and Hyper Responsiveness Ensure Stable Disease Faster
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 80 (actual)
- Sponsor
- Bispebjerg Hospital · Academic / Other
- Sex
- All
- Age
- 15 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
The application of biomarkers that are more closely associated with eosinophillic airway inflammation, such as measurements of FeNO level, cell count in induced sputum or bronchial reactivity could improve asthma control by better directing treatment. A systematic review and meta-analysis is to be conducted to assess the efficacy of tailoring asthma intervention on clinical symptoms compared with exhaled nitric oxide or induced sputum count.
Detailed description
AHR used as outcome
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pulmicort | ACQ and FeNO |
Timeline
- Start date
- 2012-11-01
- Primary completion
- 2015-01-01
- Completion
- 2015-01-01
- First posted
- 2013-11-07
- Last updated
- 2020-02-05
Locations
2 sites across 1 country: Denmark
Source: ClinicalTrials.gov record NCT01978678. Inclusion in this directory is not an endorsement.